Envista Holdings Corporation (NVST)Healthcare | Medical Instruments & Supplies | Brea, United States | NYSE
22.90 USD
-0.60
(-2.553%) ⇩
(Oct. 16, 2026, 4 p.m.
EDT)
After hours: 22.90 |
Hot Take ↕ | Oct. 10, 2026, 3:04 a.m. EDT
The investment case for Envista is currently bifurcated between a compelling fundamental turnaround story and a lack of immediate catalysts to drive the price higher. Fundamentally, the company shows signs of life: revenue grew 7.1% and earnings surged 113%, with the forward P/E dropping to a reasonable 13.8x, implying the market has priced in a difficult past. However, the price action tells a different story; the stock is down 34% over the last six years and is currently trading below its 50-day moving average, reflecting lingering skepticism about cash flow and execution. The options market is screaming 'bullish,' with heavy positioning at $30 strikes, which suggests smart money sees a path to recovery, but the underlying fundamentals haven't yet proven sustainable enough to command a premium valuation. Without a confirmed trend reversal in the price history or a clearer picture of free cash flow generation, the risk-reward remains balanced rather than tilted toward a high-conviction buy. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.112681 |
| AutoETS | 0.113248 |
| MSTL | 0.119548 |
| AutoTheta | 0.123940 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 38% |
| H-stat | 50.02 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.066 |
| Excess Kurtosis | -1.69 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 51.62 |
| Revenue per Share | 17.407 |
| Market Cap | 3,678,145,536 |
| Trailing P/E | 39.48 |
| Forward P/E | 13.76 |
| Beta | 0.89 |
| Profit Margins | 3.33% |
| Website | https://envistaco.com |
As of Oct. 10, 2026, 3:04 a.m. EDT: Speculators are positioning for a significant upside move, evidenced by massive open interest in $30 calls (6.5k contracts) compared to negligible put volume. This creates a distinct gamma exposure profile where the market expects a rally to test resistance levels. Conversely, put writers are heavily concentrated at lower strikes ($17.50-$20.00), suggesting a floor is being established there, while call writers are exposed at higher strikes, indicating a bullish skew in sentiment despite the stock trading below its 50-day average.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.13704073 |
| Address1 | Building E |
| Address2 | 200 South Kraemer Boulevard |
| All Time High | 52.03 |
| All Time Low | 10.08 |
| Ask | 22.86 |
| Ask Size | 200 |
| Audit Risk | 2 |
| Average Analyst Rating | 2.2 - Buy |
| Average Daily Volume10 Day | 2,378,330 |
| Average Daily Volume3 Month | 2,769,712 |
| Average Volume | 2,769,712 |
| Average Volume10Days | 2,378,330 |
| Beta | 0.888 |
| Bid | 22.93 |
| Bid Size | 200 |
| Board Risk | 4 |
| Book Value | 19.155 |
| City | Brea |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 4 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 22.9 |
| Current Ratio | 2.425 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 23.669 |
| Day Low | 22.81 |
| Debt To Equity | 51.62 |
| Display Name | Envista |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,793,822,400 |
| Earnings Call Timestamp Start | 1,793,822,400 |
| Earnings Growth | 1.113 |
| Earnings Quarterly Growth | 1.034 |
| Earnings Timestamp | 1,793,822,400 |
| Earnings Timestamp End | 1,793,822,400 |
| Earnings Timestamp Start | 1,793,822,400 |
| Ebitda | 406,200,000 |
| Ebitda Margins | 0.14220001 |
| Enterprise To Ebitda | 10.193 |
| Enterprise To Revenue | 1.45 |
| Enterprise Value | 4,140,545,536 |
| Eps Current Year | 1.53067 |
| Eps Forward | 1.66409 |
| Eps Trailing Twelve Months | 0.58 |
| Esg Populated | 0 |
| Exchange | NYQ |
| Exchange Data Delayed By | 20 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 714 817 5450 |
| Fifty Day Average | 25.477 |
| Fifty Day Average Change | -2.5769997 |
| Fifty Day Average Change Percent | -0.10115004 |
| Fifty Two Week Change Percent | 13.704073 |
| Fifty Two Week High | 30.42 |
| Fifty Two Week High Change | -7.5200005 |
| Fifty Two Week High Change Percent | -0.2472058 |
| Fifty Two Week Low | 18.77 |
| Fifty Two Week Low Change | 4.129999 |
| Fifty Two Week Low Change Percent | 0.22003192 |
| Fifty Two Week Range | 18.77 - 30.42 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,568,813,400,000 |
| Float Shares | 159,867,624 |
| Forward Eps | 1.66409 |
| Forward P E | 13.761274 |
| Free Cashflow | 267,887,504 |
| Full Exchange Name | NYSE |
| Full Time Employees | 12,000 |
| Fullday Change | -0.6000004 |
| Fullday Change Percent | -2.553193 |
| Fullday Price | 22.9 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.55421 |
| Gross Profits | 1,583,100,032 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0058999998 |
| Held Percent Institutions | 1.20122 |
| Implied Shares Outstanding | 160,617,709 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California. |
| Long Name | Envista Holdings Corporation |
| Market | us_market |
| Market Cap | 3,678,145,536 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_629627778 |
| Most Recent Quarter | 1,783,036,800 |
| Net Income To Common | 95,000,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 3,825,913,828 |
| Number Of Analyst Opinions | 13 |
| Open | 23.5 |
| Operating Cashflow | 302,600,000 |
| Operating Margins | 0.1039 |
| Overall Risk | 4 |
| Payout Ratio | 0.0 |
| Phone | 714 817 7000 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 22.9 |
| Post Market Time | 1,792,180,858 |
| Previous Close | 23.5 |
| Price Eps Current Year | 14.960768 |
| Price Hint | 2 |
| Price To Book | 1.1955103 |
| Price To Sales Trailing12 Months | 1.2876407 |
| Profit Margins | 0.03326 |
| Quick Ratio | 1.935 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 2.2 |
| Region | US |
| Regular Market Change | -0.6 |
| Regular Market Change Percent | -2.55319 |
| Regular Market Day High | 23.669 |
| Regular Market Day Low | 22.81 |
| Regular Market Day Range | 22.81 - 23.669 |
| Regular Market Open | 23.5 |
| Regular Market Previous Close | 23.5 |
| Regular Market Price | 22.9 |
| Regular Market Time | 1,792,180,803 |
| Regular Market Volume | 2,324,175 |
| Return On Assets | 0.03229 |
| Return On Equity | 0.030569999 |
| Revenue Growth | 0.071 |
| Revenue Per Share | 17.407 |
| Sand P52 Week Change | 0.13723719 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 5 |
| Shares Outstanding | 160,617,709 |
| Shares Percent Shares Out | 0.0752 |
| Shares Short | 12,072,597 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 11,382,180 |
| Short Name | Envista Holdings Corporation |
| Short Percent Of Float | 0.0844 |
| Short Ratio | 4.12 |
| Source Interval | 15 |
| State | CA |
| Symbol | NVST |
| Target High Price | 34.0 |
| Target Low Price | 23.0 |
| Target Mean Price | 28.69231 |
| Target Median Price | 28.0 |
| Total Cash | 1,125,600,000 |
| Total Cash Per Share | 7.008 |
| Total Debt | 1,588,000,000 |
| Total Revenue | 2,856,499,968 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.58 |
| Trailing P E | 39.482758 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 25.71055 |
| Two Hundred Day Average Change | -2.8105507 |
| Two Hundred Day Average Change Percent | -0.109315075 |
| Type Disp | Equity |
| Volume | 2,324,175 |
| Website | https://envistaco.com |
| Zip | 92,821-6208 |